DXR Q2 2024 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena

DXRDaxor Corporation

$58M

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$71,756-11.4% YoY

Gross Profit

$71,756100.0% margin

Operating Income

-$297,550-414.7% margin

Net Income

-$2M-2272.7% margin

EPS (Diluted)

$-0.34

Cash Flow

Operating Cash Flow

-$893,984

Free Cash Flow

-$893,990

Stock-Based Comp.

$275,696

Balance Sheet

Total Assets

$34M

Total Liabilities

$2M

Stockholders' Equity

$33M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71,756	$80,974	-11.4%
Gross Profit	$71,756	$80,974	-11.4%
Operating Income	-$297,550	-$366,458	+18.8%
Net Income	-$2M	-$3M	+46.3%